Advertisement

Index by author

January 01, 1983; Volume 23,Issue 1

A

  1. Abe, T

    1. Purification and characterization of three forms of microsomal cytochrome P-450 in liver from 3-methylcholanthrene-treated guinea pigs.
      T Abe and M Watanabe
      Molecular Pharmacology January 1983, 23 (1) 258-264;

  2. Ackerman, S

    1. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
      C T Noguchi, S Ackerman, J DiMaio, P W Schiller and A N Schechter
      Molecular Pharmacology January 1983, 23 (1) 100-103;

  3. Arora, S K

    1. Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV.
      S K Arora
      Molecular Pharmacology January 1983, 23 (1) 133-140;

B

  1. Balzarini, J

    1. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
      J Balzarini and E De Clercq
      Molecular Pharmacology January 1983, 23 (1) 175-181;

  2. Belt, J A

    1. Transport of uridine and 6-azauridine in human lymphoblastoid cells. Specificity for the uncharged 6-azauridine molecule.
      J A Belt and A D Welch
      Molecular Pharmacology January 1983, 23 (1) 153-158;

  3. Brown, R D

    1. The influence of antibiotics on agonist occupation and functional states of the nicotinic acetylcholine receptor.
      R D Brown and P Taylor
      Molecular Pharmacology January 1983, 23 (1) 8-16;

  4. Bullard, W P

    1. Steady-state kinetics of bovine striatal tyrosine hydroxylase.
      W P Bullard and T L Capson
      Molecular Pharmacology January 1983, 23 (1) 104-111;

  5. Burch, T P

    1. Group-selective reagent modification of the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex reveals that low-affinity gamma-aminobutyric acid receptors stimulate benzodiazepine binding.
      T P Burch, R Thyagarajan and M K Ticku
      Molecular Pharmacology January 1983, 23 (1) 52-59;

  6. Burstein, S

    1. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
      S Burstein, S A Hunter and K Ozman
      Molecular Pharmacology January 1983, 23 (1) 121-126;

C

  1. Cabantchik, Z I

    1. Anion transport inhibitors as suppressors of Plasmodium falciparum growth in in vitro cultures.
      Z I Cabantchik, S Kutner, M Krugliak and H Ginsburg
      Molecular Pharmacology January 1983, 23 (1) 92-99;

  2. Capson, T L

    1. Steady-state kinetics of bovine striatal tyrosine hydroxylase.
      W P Bullard and T L Capson
      Molecular Pharmacology January 1983, 23 (1) 104-111;

  3. Chavkin, C

    1. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
      B M Cox and C Chavkin
      Molecular Pharmacology January 1983, 23 (1) 36-43;

  4. Cheng, Y C

    1. Human deoxycytidylate deaminase. Substrate and regulator specificities and their chemotherapeutic implications.
      W R Mancini and Y C Cheng
      Molecular Pharmacology January 1983, 23 (1) 159-164;
    2. Effects of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells.
      Y C Cheng and K Nakayama
      Molecular Pharmacology January 1983, 23 (1) 171-174;

  5. Chiang, J Y

    1. Effect of inducers and aging on rabbit liver microsomal drug-metabolizing enzymes.
      J Y Chiang, A G DiLella and A W Steggles
      Molecular Pharmacology January 1983, 23 (1) 244-251;

  6. Cox, B M

    1. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
      B M Cox and C Chavkin
      Molecular Pharmacology January 1983, 23 (1) 36-43;

D

  1. De Clercq, E

    1. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
      J Balzarini and E De Clercq
      Molecular Pharmacology January 1983, 23 (1) 175-181;

  2. DiLella, A G

    1. Effect of inducers and aging on rabbit liver microsomal drug-metabolizing enzymes.
      J Y Chiang, A G DiLella and A W Steggles
      Molecular Pharmacology January 1983, 23 (1) 244-251;

  3. DiMaio, J

    1. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
      C T Noguchi, S Ackerman, J DiMaio, P W Schiller and A N Schechter
      Molecular Pharmacology January 1983, 23 (1) 100-103;

  4. Dyroff, M C

    1. Studies of the mechanism of metabolism of thioacetamide s-oxide by rat liver microsomes.
      M C Dyroff and R A Neal
      Molecular Pharmacology January 1983, 23 (1) 219-227;

E

  1. Earle, M F

    1. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
      M F Earle and R I Glazer
      Molecular Pharmacology January 1983, 23 (1) 165-170;

F

  1. Fahl, W E

    1. Benz[a]anthracene and 3-methylcholanthrene induction of cytochrome P-450 in C3H/10T1/2 mouse fibroblasts. Modulating role of cytotoxic 3-methylcholanthrene metabolites.
      D Ho, K Gill and W E Fahl
      Molecular Pharmacology January 1983, 23 (1) 198-205;

  2. Felig, P

    1. 3-O-methyl-D-glucose uptake in isolated rat hepatocytes. Effects of dexamethasone.
      Z Madar and P Felig
      Molecular Pharmacology January 1983, 23 (1) 141-145;

G

  1. García-Sáinz, J A

    1. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects.
      J Huerta-Bahena, R Villalobos-Molina and J A García-Sáinz
      Molecular Pharmacology January 1983, 23 (1) 67-70;

  2. Gati, W P

    1. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
      W P Gati, E E Knaus and L I Wiebe
      Molecular Pharmacology January 1983, 23 (1) 146-152;

  3. Gill, K

    1. Benz[a]anthracene and 3-methylcholanthrene induction of cytochrome P-450 in C3H/10T1/2 mouse fibroblasts. Modulating role of cytotoxic 3-methylcholanthrene metabolites.
      D Ho, K Gill and W E Fahl
      Molecular Pharmacology January 1983, 23 (1) 198-205;

  4. Ginsburg, H

    1. Anion transport inhibitors as suppressors of Plasmodium falciparum growth in in vitro cultures.
      Z I Cabantchik, S Kutner, M Krugliak and H Ginsburg
      Molecular Pharmacology January 1983, 23 (1) 92-99;

  5. Glazer, R I

    1. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
      M F Earle and R I Glazer
      Molecular Pharmacology January 1983, 23 (1) 165-170;

  6. Goldstein, D B

    1. Changes in synaptic membrane order associated with chronic ethanol treatment in mice.
      R C Lyon and D B Goldstein
      Molecular Pharmacology January 1983, 23 (1) 86-91;

  7. Goldstein, J A

    1. Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure.
      M I Luster, L D Lawson, P Linko and J A Goldstein
      Molecular Pharmacology January 1983, 23 (1) 252-257;

  8. Guchhait, R B

    1. Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
      J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
      Molecular Pharmacology January 1983, 23 (1) 112-120;

  9. Gustafsson, J A

    1. Xylene induces a cytochrome P-450 isozyme in rat liver similar to the major isozyme induced by phenobarbital.
      R Toftgård, J Halpert and J A Gustafsson
      Molecular Pharmacology January 1983, 23 (1) 265-271;

H

  1. Haas, Y

    1. Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.
      M H Perrin, Y Haas, J E Rivier and W W Vale
      Molecular Pharmacology January 1983, 23 (1) 44-51;

  2. Hakala, M T

    1. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.
      M B Yin, S F Zakrzewski and M T Hakala
      Molecular Pharmacology January 1983, 23 (1) 190-197;

  3. Halpert, J

    1. Xylene induces a cytochrome P-450 isozyme in rat liver similar to the major isozyme induced by phenobarbital.
      R Toftgård, J Halpert and J A Gustafsson
      Molecular Pharmacology January 1983, 23 (1) 265-271;

  4. Hasegawa, T

    1. Effects of phenobarbital and 3-methylcholanthrene pretreatments on monooxygenase activities and proportions of isolated rat hepatocyte subpopulations.
      K Tonda, T Hasegawa and M Hirata
      Molecular Pharmacology January 1983, 23 (1) 235-243;

  5. Hirata, M

    1. Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin.
      M Hirata, E Suematsu and T Koga
      Molecular Pharmacology January 1983, 23 (1) 78-85;
    2. Effects of phenobarbital and 3-methylcholanthrene pretreatments on monooxygenase activities and proportions of isolated rat hepatocyte subpopulations.
      K Tonda, T Hasegawa and M Hirata
      Molecular Pharmacology January 1983, 23 (1) 235-243;

  6. Hirayama, N

    1. Conformations of fortimicins and three-dimensional structure-activity relationship in the aminoglycoside antibiotics.
      N Hirayama, K Shirahata, Y Ohashi and Y Sasada
      Molecular Pharmacology January 1983, 23 (1) 127-132;

  7. Ho, D

    1. Benz[a]anthracene and 3-methylcholanthrene induction of cytochrome P-450 in C3H/10T1/2 mouse fibroblasts. Modulating role of cytotoxic 3-methylcholanthrene metabolites.
      D Ho, K Gill and W E Fahl
      Molecular Pharmacology January 1983, 23 (1) 198-205;

  8. Hom, D S

    1. Opiate regulation of adenosine 3':5'-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect.
      P Y Law, D S Hom and H H Loh
      Molecular Pharmacology January 1983, 23 (1) 26-35;

  9. Hook, J B

    1. Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration.
      C R Wolf, J B Hook and E A Lock
      Molecular Pharmacology January 1983, 23 (1) 206-212;

  10. Huerta-Bahena, J

    1. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects.
      J Huerta-Bahena, R Villalobos-Molina and J A García-Sáinz
      Molecular Pharmacology January 1983, 23 (1) 67-70;

  11. Hunter, S A

    1. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
      S Burstein, S A Hunter and K Ozman
      Molecular Pharmacology January 1983, 23 (1) 121-126;

  12. Hurst, J H

    1. Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
      J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
      Molecular Pharmacology January 1983, 23 (1) 112-120;

J

  1. Jacoby, R

    1. High-affinity, divalent ion-specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Comparison with divalent-ion ATPase activity.
      R M Levin, R Jacoby and A J Wein
      Molecular Pharmacology January 1983, 23 (1) 1-7;

  2. Jenden, D J

    1. Affinity, efficacy, and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea pig ileum.
      B Ringdahl and D J Jenden
      Molecular Pharmacology January 1983, 23 (1) 17-25;

K

  1. Kato, R

    1. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Molecular Pharmacology January 1983, 23 (1) 228-234;

  2. Knaus, E E

    1. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
      W P Gati, E E Knaus and L I Wiebe
      Molecular Pharmacology January 1983, 23 (1) 146-152;

  3. Koga, T

    1. Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin.
      M Hirata, E Suematsu and T Koga
      Molecular Pharmacology January 1983, 23 (1) 78-85;

  4. Krugliak, M

    1. Anion transport inhibitors as suppressors of Plasmodium falciparum growth in in vitro cultures.
      Z I Cabantchik, S Kutner, M Krugliak and H Ginsburg
      Molecular Pharmacology January 1983, 23 (1) 92-99;

  5. Kutner, S

    1. Anion transport inhibitors as suppressors of Plasmodium falciparum growth in in vitro cultures.
      Z I Cabantchik, S Kutner, M Krugliak and H Ginsburg
      Molecular Pharmacology January 1983, 23 (1) 92-99;

L

  1. Law, P Y

    1. Opiate regulation of adenosine 3':5'-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect.
      P Y Law, D S Hom and H H Loh
      Molecular Pharmacology January 1983, 23 (1) 26-35;

  2. Lawson, L D

    1. Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure.
      M I Luster, L D Lawson, P Linko and J A Goldstein
      Molecular Pharmacology January 1983, 23 (1) 252-257;

  3. Lefort, G P

    1. Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
      J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
      Molecular Pharmacology January 1983, 23 (1) 112-120;

  4. Le Pecq, J B

    1. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
      F Y WU and J B Le Pecq
      Molecular Pharmacology January 1983, 23 (1) 182-189;

  5. Levin, R M

    1. High-affinity, divalent ion-specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Comparison with divalent-ion ATPase activity.
      R M Levin, R Jacoby and A J Wein
      Molecular Pharmacology January 1983, 23 (1) 1-7;

  6. Linko, P

    1. Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure.
      M I Luster, L D Lawson, P Linko and J A Goldstein
      Molecular Pharmacology January 1983, 23 (1) 252-257;

  7. Lock, E A

    1. Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration.
      C R Wolf, J B Hook and E A Lock
      Molecular Pharmacology January 1983, 23 (1) 206-212;

  8. Loh, H H

    1. Opiate regulation of adenosine 3':5'-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect.
      P Y Law, D S Hom and H H Loh
      Molecular Pharmacology January 1983, 23 (1) 26-35;

  9. Luster, M I

    1. Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure.
      M I Luster, L D Lawson, P Linko and J A Goldstein
      Molecular Pharmacology January 1983, 23 (1) 252-257;

  10. Lyon, R C

    1. Changes in synaptic membrane order associated with chronic ethanol treatment in mice.
      R C Lyon and D B Goldstein
      Molecular Pharmacology January 1983, 23 (1) 86-91;

M

  1. Madar, Z

    1. 3-O-methyl-D-glucose uptake in isolated rat hepatocytes. Effects of dexamethasone.
      Z Madar and P Felig
      Molecular Pharmacology January 1983, 23 (1) 141-145;

  2. Mancini, W R

    1. Human deoxycytidylate deaminase. Substrate and regulator specificities and their chemotherapeutic implications.
      W R Mancini and Y C Cheng
      Molecular Pharmacology January 1983, 23 (1) 159-164;

  3. McKinney, J S

    1. Effects of antimycin A on receptor-activated calcium mobilization and phosphoinositide metabolism in rat parotid gland.
      J Poggioli, S J Weiss, J S McKinney and J W Putney
      Molecular Pharmacology January 1983, 23 (1) 71-77;

N

  1. Nakadate, T

    1. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Molecular Pharmacology January 1983, 23 (1) 228-234;

  2. Nakaki, T

    1. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Molecular Pharmacology January 1983, 23 (1) 228-234;

  3. Nakayama, K

    1. Effects of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells.
      Y C Cheng and K Nakayama
      Molecular Pharmacology January 1983, 23 (1) 171-174;

  4. Neal, R A

    1. Studies of the mechanism of metabolism of thioacetamide s-oxide by rat liver microsomes.
      M C Dyroff and R A Neal
      Molecular Pharmacology January 1983, 23 (1) 219-227;

  5. Nisula, B C

    1. Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
      J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
      Molecular Pharmacology January 1983, 23 (1) 112-120;

  6. Noguchi, C T

    1. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
      C T Noguchi, S Ackerman, J DiMaio, P W Schiller and A N Schechter
      Molecular Pharmacology January 1983, 23 (1) 100-103;

O

  1. Ohashi, Y

    1. Conformations of fortimicins and three-dimensional structure-activity relationship in the aminoglycoside antibiotics.
      N Hirayama, K Shirahata, Y Ohashi and Y Sasada
      Molecular Pharmacology January 1983, 23 (1) 127-132;

  2. Ozman, K

    1. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
      S Burstein, S A Hunter and K Ozman
      Molecular Pharmacology January 1983, 23 (1) 121-126;

P

  1. Perrin, M H

    1. Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.
      M H Perrin, Y Haas, J E Rivier and W W Vale
      Molecular Pharmacology January 1983, 23 (1) 44-51;

  2. Poggioli, J

    1. Effects of antimycin A on receptor-activated calcium mobilization and phosphoinositide metabolism in rat parotid gland.
      J Poggioli, S J Weiss, J S McKinney and J W Putney
      Molecular Pharmacology January 1983, 23 (1) 71-77;

  3. Protić-Sabljić, M

    1. Quantitative structure-activity study on the mechanism of inhibition of microsomal p-hydroxylation of aniline by alcohols. Role of steric factors.
      A Sabljić and M Protić-Sabljić
      Molecular Pharmacology January 1983, 23 (1) 213-218;

  4. Putney, J W

    1. Effects of antimycin A on receptor-activated calcium mobilization and phosphoinositide metabolism in rat parotid gland.
      J Poggioli, S J Weiss, J S McKinney and J W Putney
      Molecular Pharmacology January 1983, 23 (1) 71-77;

R

  1. Ringdahl, B

    1. Affinity, efficacy, and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea pig ileum.
      B Ringdahl and D J Jenden
      Molecular Pharmacology January 1983, 23 (1) 17-25;

  2. Rivier, J E

    1. Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.
      M H Perrin, Y Haas, J E Rivier and W W Vale
      Molecular Pharmacology January 1983, 23 (1) 44-51;

S

  1. Sabljić, A

    1. Quantitative structure-activity study on the mechanism of inhibition of microsomal p-hydroxylation of aniline by alcohols. Role of steric factors.
      A Sabljić and M Protić-Sabljić
      Molecular Pharmacology January 1983, 23 (1) 213-218;

  2. Sasada, Y

    1. Conformations of fortimicins and three-dimensional structure-activity relationship in the aminoglycoside antibiotics.
      N Hirayama, K Shirahata, Y Ohashi and Y Sasada
      Molecular Pharmacology January 1983, 23 (1) 127-132;

  3. Schechter, A N

    1. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
      C T Noguchi, S Ackerman, J DiMaio, P W Schiller and A N Schechter
      Molecular Pharmacology January 1983, 23 (1) 100-103;

  4. Schiller, P W

    1. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
      C T Noguchi, S Ackerman, J DiMaio, P W Schiller and A N Schechter
      Molecular Pharmacology January 1983, 23 (1) 100-103;

  5. Shirahata, K

    1. Conformations of fortimicins and three-dimensional structure-activity relationship in the aminoglycoside antibiotics.
      N Hirayama, K Shirahata, Y Ohashi and Y Sasada
      Molecular Pharmacology January 1983, 23 (1) 127-132;

  6. Steggles, A W

    1. Effect of inducers and aging on rabbit liver microsomal drug-metabolizing enzymes.
      J Y Chiang, A G DiLella and A W Steggles
      Molecular Pharmacology January 1983, 23 (1) 244-251;

  7. Stolk, J M

    1. Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
      J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
      Molecular Pharmacology January 1983, 23 (1) 112-120;

  8. Suematsu, E

    1. Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin.
      M Hirata, E Suematsu and T Koga
      Molecular Pharmacology January 1983, 23 (1) 78-85;

T

  1. Taylor, P

    1. The influence of antibiotics on agonist occupation and functional states of the nicotinic acetylcholine receptor.
      R D Brown and P Taylor
      Molecular Pharmacology January 1983, 23 (1) 8-16;

  2. Thyagarajan, R

    1. Group-selective reagent modification of the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex reveals that low-affinity gamma-aminobutyric acid receptors stimulate benzodiazepine binding.
      T P Burch, R Thyagarajan and M K Ticku
      Molecular Pharmacology January 1983, 23 (1) 52-59;

  3. Ticku, M K

    1. Group-selective reagent modification of the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex reveals that low-affinity gamma-aminobutyric acid receptors stimulate benzodiazepine binding.
      T P Burch, R Thyagarajan and M K Ticku
      Molecular Pharmacology January 1983, 23 (1) 52-59;

  4. Toftgård, R

    1. Xylene induces a cytochrome P-450 isozyme in rat liver similar to the major isozyme induced by phenobarbital.
      R Toftgård, J Halpert and J A Gustafsson
      Molecular Pharmacology January 1983, 23 (1) 265-271;

  5. Tonda, K

    1. Effects of phenobarbital and 3-methylcholanthrene pretreatments on monooxygenase activities and proportions of isolated rat hepatocyte subpopulations.
      K Tonda, T Hasegawa and M Hirata
      Molecular Pharmacology January 1983, 23 (1) 235-243;

V

  1. Vale, W W

    1. Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.
      M H Perrin, Y Haas, J E Rivier and W W Vale
      Molecular Pharmacology January 1983, 23 (1) 44-51;

  2. Vantini, G

    1. Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
      J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
      Molecular Pharmacology January 1983, 23 (1) 112-120;

  3. Villalobos-Molina, R

    1. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects.
      J Huerta-Bahena, R Villalobos-Molina and J A García-Sáinz
      Molecular Pharmacology January 1983, 23 (1) 67-70;

W

  1. Wallace, R M

    1. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
      R M Wallace and J M Young
      Molecular Pharmacology January 1983, 23 (1) 60-66;

  2. Watanabe, M

    1. Purification and characterization of three forms of microsomal cytochrome P-450 in liver from 3-methylcholanthrene-treated guinea pigs.
      T Abe and M Watanabe
      Molecular Pharmacology January 1983, 23 (1) 258-264;

  3. Wein, A J

    1. High-affinity, divalent ion-specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Comparison with divalent-ion ATPase activity.
      R M Levin, R Jacoby and A J Wein
      Molecular Pharmacology January 1983, 23 (1) 1-7;

  4. Weiss, S J

    1. Effects of antimycin A on receptor-activated calcium mobilization and phosphoinositide metabolism in rat parotid gland.
      J Poggioli, S J Weiss, J S McKinney and J W Putney
      Molecular Pharmacology January 1983, 23 (1) 71-77;

  5. Welch, A D

    1. Transport of uridine and 6-azauridine in human lymphoblastoid cells. Specificity for the uncharged 6-azauridine molecule.
      J A Belt and A D Welch
      Molecular Pharmacology January 1983, 23 (1) 153-158;

  6. Wiebe, L I

    1. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
      W P Gati, E E Knaus and L I Wiebe
      Molecular Pharmacology January 1983, 23 (1) 146-152;

  7. Wolf, C R

    1. Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration.
      C R Wolf, J B Hook and E A Lock
      Molecular Pharmacology January 1983, 23 (1) 206-212;

  8. WU, F Y

    1. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
      F Y WU and J B Le Pecq
      Molecular Pharmacology January 1983, 23 (1) 182-189;

Y

  1. Yamamoto, S

    1. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Molecular Pharmacology January 1983, 23 (1) 228-234;

  2. Yin, M B

    1. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.
      M B Yin, S F Zakrzewski and M T Hakala
      Molecular Pharmacology January 1983, 23 (1) 190-197;

  3. Young, J M

    1. Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
      R M Wallace and J M Young
      Molecular Pharmacology January 1983, 23 (1) 60-66;

Z

  1. Zakrzewski, S F

    1. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.
      M B Yin, S F Zakrzewski and M T Hakala
      Molecular Pharmacology January 1983, 23 (1) 190-197;
Back to top

In this issue

Advertisement